Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart
Susmita Sahoo, Ph.D.
Associate Professor
Cardiovascular Research Institute
Icahn School of Medicine at Mount Sinai
Pioneers in Biomedical Research Seminar
Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart
Date: April 11, 2025
Time: 11 a.m. - 12 p.m.
About this Seminar
The recent explosion in extracellular vesicle (EV) research underscores their significance as messengers of health and disease. In this talk, Dr. Sahoo will highlight their dual role as novel therapeutic gene delivery vectors to treat heart failure with cardiac gene therapy and as disease disseminators in patients with chronic kidney disease and type 1 diabetes causing heart failure. Dr. Sahoo will highlight potential applications of EVs in cardiovascular pathogenesis, diagnosis, biomarker discovery, and therapeutics.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Vascular and Heart Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , homeMay 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Targeting Acquired Dependencies During Tumor Evolution , homeJune 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.